Indian health workers have been warned that cancer treatment in India is expensive, and the average cost of a tumour is Rs500,000, according to a report by a health group.
The Indian National Cancer Society said a report of its annual health conference in Delhi on Tuesday showed that out of the total number of people with tumours in the country, more than 2.8 million were suffering from cancer.
The study also said that in India, almost 80% of patients have no treatment option left, and that over 50% of all cancer patients have been discharged, the health body said.
The conference was organised by the National Cancer Control Council, which aims to tackle the spread of cancer worldwide and to help develop better health systems and policies.
The report was based on data from an Indian health programme, called Cancer Survival and Response, which helps patients cope with the complications of cancer and provides information about treatment options.
According to the report, more Indian hospitals have had tumours than the number of patients admitted to hospitals nationwide.
“India’s population is expected to reach 1.5 billion by 2025, making it the world’s largest nation by population,” the report said.
“At the same time, the number and number of cancer patients is expected grow significantly, as they are now the fastest growing age group.”
While the average price of a cancer treatment is $1,500 per patient, India has a national average of around $600,000.
It is one of the lowest-cost countries in the world.
In India, only about 3% of the patients in hospitals have access to quality cancer care.
The cost of cancer treatment varies widely, according the report.
“The average cost for cancer treatment for India in 2019 was around $1.3 million, but this has increased significantly in recent years,” it said.
In recent years, India’s average annual cost of treatment has been about $2.4 billion, but the report showed that a major factor in this is the high cost of drugs, which can cost upwards of $400,000 in India.
The number of new cancer patients has doubled in the past 10 years to 1.3million, while the number discharged from hospital for cancer has nearly doubled to about 200,000 since 2014, the report noted.
“Our study suggests that the cost of treating cancer patients and cancer patients alone is an additional source of funding for cancer control and cancer control programmes,” said Dr Rajesh Kumar, the group’s chief medical officer.